0001127602-18-037522.txt : 20181231
0001127602-18-037522.hdr.sgml : 20181231
20181231083925
ACCESSION NUMBER: 0001127602-18-037522
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151008
FILED AS OF DATE: 20181231
DATE AS OF CHANGE: 20181231
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Faleck Herbert J
CENTRAL INDEX KEY: 0001652994
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 181258685
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1600
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edge Therapeutics, Inc.
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0306
4/A
2015-10-08
2015-10-08
1
0001472091
Edge Therapeutics, Inc.
EDGE
0001652994
Faleck Herbert J
300 CONNELL DRIVE
SUITE 4000
BERKELEY HEIGHTS
NJ
07922
1
Chief Medical Officer
Common Stock
32061.25
I
401(K) Plan
Reflects periodic contributions to the issuer's common stock fund in the issuer's 401(K) Plan as of December 28, 2018. This amendment is being filed to include these shares of the issuer's common stock that were omitted in the prior report.
/s/ Herbert J. Faleck, Reporting Person
2018-12-31